ArticleJournal of advanced research2026
Ciliary IFT88 inhibits intervertebral disc degeneration under excessive mechanical stress by regulating endplate cartilage calcification.
Article in Journal of advanced research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Biomaterials for intervertebral disc regeneration: Niche reprogramming, precision therapeutics, and structural reconstruction.Bioactive materials · 2027Review
- From Modic changes to the disc-endplate-bone marrow complex: imaging stratification, immune remodeling, and translational implications in intervertebral disc degeneration.Frontiers in immunology · 2026Review
- From mechanotransduction to manual therapy: advances in piezo/TRP channels and lumbar degeneration.Frontiers in physiology · 2026Review
- Mechanotransduction in intervertebral disc degeneration: from compartment-specific sensors to translational frontiers.Frontiers in bioengineering and biotechnology · 2026Review
- DDRGK1 preserves intervertebral disc development through ufmylation.Cellular and molecular life sciences : CMLS · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionEndplate cartilage is crucial for nutrient transport to intervertebral disc (IVD), and its calcification due to abnormal mechanical stress significantly contributes to intervertebral disc degeneration (IDD). Primary cilia, which sense mechanical stimuli, are key to this process. Intraflagellar Transport 88 (IFT88) regulates endplate calcification under mechanical stress, but its specific mechanisms remain inadequately characterized.
objectivesWe aimed to elucidate the role and regulatory mechanisms of IFT88 in primary cilia in endplate cartilage calcification and IVD.
methodsChanges in IFT88 expression in endplate cartilage and its response to mechanical stress were assessed using histochemical staining, Western blotting, immunofluorescence, and transmission electron microscopy. The relationship between abnormal stress and calcium ions was explored through RNA sequencing, qPCR, and calcium staining. In vitro studies investigated the regulatory mechanisms of IFT88 in chondrocytes subjected to abnormal stress using molecular docking, co-immunoprecipitation, dual-luciferase assays, and flow cytometry. Rats tail crush model confirmed the role of IFT88 in chondral calcification and IDD as a potential therapeutic target.
resultsAs intervertebral disc degeneration progresses, IFT88 expression in the primary cilia of cartilage endplate cells decreased. Under normal stress conditions, IFT88 levels increased with the intensity and duration of stress; however, excessively high stress triggered mechanisms that led to cilia depletion. Elevated intracellular calcium concentrations under tensile stress contributed to endplate calcification and IDD. Additionally, IFT88 negatively regulated its positive transcription factor C/EBPα under abnormal stress, potentially contributing to cilia depletion. IFT88 also inhibited the hyperactivation of transient receptor potential vanilloid 4 (TRPV4), reducing calcium influx and alleviating oxidative stress and Wnt pathway activation. In vivo studies showed that overexpressing IFT88 maintains disc height and structural integrity while reducing endplate ossification.
conclusionOur study demonstrates that IFT88 inhibits TRPV4, thereby protecting endplate cartilage and positioning IFT88 as a promising therapeutic target for IDD and endplate calcification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.